Creative BioMart to Present at BPS 2025 Annual Meeting | February 15-19, 2025

Recombinant Cynomolgus CD200R1L protein, His-tagged

Cat.No. : CD200R1L-0279C
Product Overview : Recombinant Cynomolgus CD200R1L protein(Met1-Ser240), fused with His tag, was expressed in HEK293.
  • Specification
  • Gene Information
  • Related Products
  • Download
Source : HEK293
Species : Cynomolgus
Tag : His
Form : Lyophilized from sterile PBS, pH 7.4.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hard copy of CoA.
Molecular Mass : The recombinant Cynomolgus CD200R1L consists of 224 amino acids and predicts a molecular mass of 25.18 kDa. It migrates as an approximately 52.71 kDa band in SDS-PAGE under reducing conditions.
Proteinlength : Met1-Ser240
Endotoxin : < 1.0 EU per μg protein as determined by the LAL method.
Purity : > 95 % as determined by SDS-PAGE.
Storage : Samples are stable for up to twelve months from date of receipt at -20°C to -80°C
Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution : It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.
Protein length : Met1-Ser240

Not For Human Consumption!

Inquiry

  • Reviews
  • Q&As

Customer Reviews (3)

Write a review
Reviews
10/27/2022

    The wide range of applications of CD200R1L shows its important role in scientific research and provides strong support for scientific research.

    07/06/2021

      After using CD200R1L, the background of the Western blot was very clean with no nonspecific signal.

      01/08/2020

        This stability of CD200R1L was still very good in the process of performing complex biological experiments, indicating that it has excellent within-batch and between-batch stability.

        Q&As (6)

        Ask a question
        How does the expression level of CD200R1L protein change during the development of the disease? 06/20/2022

        The expression level of CD200R1L proteins may change during the development and progression of certain diseases. For example, in some immune diseases, the expression level of CD200R1L may be down-regulated, leading to increased immune cell activity and an intensified inflammatory response. However, the association between specific changes and different diseases and the regulatory mechanism need further research to clarify.

        What are the methods of up-regulating and down-regulating CD200R1L protein? 09/06/2021

        Up-regulation and down-regulation of CD200R1L proteins can be achieved through a variety of pathways. For example, specific agonists or inhibitors can be used to modulate the signaling pathways of CD200R1L, affecting their expression and function. In addition, certain cytokines and extracellular signaling molecules may also play regulatory roles by influencing the expression of CD200R1L. Specific up-regulation and down-regulation methods need to select appropriate strategies according to the research purpose and experimental conditions.

        Is there a link between gene polymorphisms in CD200R1L proteins and susceptibility to disease? 05/08/2021

        Polymorphisms in CD200R1L genes may be associated with susceptibility to certain diseases, but this is currently not well studied. Some studies suggest that polymorphismic variations in CD200R1L genes may affect the expression level, function, and interaction with the ligand CD200, thereby affecting immunomodulatory processes. However, more research is needed to verify this association.

        What is the relationship between CD200R1L protein and tumor immune escape? 02/03/2021

        CD200R1L proteins play a role in tumor immune evasion. Studies have found that some tumor cells can inhibit the activity of CD200R1L-positive immune cells (such as macrophages, dendritic cells, etc.) by expressing CD200 ligands highly, reducing the killing effect of immune cells on tumor cells, thereby promoting tumor growth and metastasis. The regulation of CD200R1L signaling pathways may help reverse tumor immune escape and improve the effectiveness of tumor immunotherapy.

        How does CD200R1L protein play a role in immune tolerance? 01/13/2020

        It play a role in inhibiting the activity of immune cells in immune tolerance. After binding to its ligand CD200, CD200R1L reduces the production of pro-inflammatory cytokines by inhibiting the activation signaling pathway of immune cells, thereby regulating the intensity of the immune response, maintaining the balance of the immune system, and preventing tissue damage caused by excessive immune response.

        What is the potential application value of CD200R1L protein in immunotherapy? 07/04/2019

        CD200R1L proteins have potential applications in immunotherapy. Studies have shown that by regulating CD200R1L signaling pathways, immune cells can enhance the ability of immune cells to attack tumor cells and improve the effect of immunotherapy. In addition, the regulatory role of CD200R1L in autoimmune diseases may also provide new ideas for the treatment of related diseases.

        Ask a Question for All CD200R1L Products

        Required fields are marked with *

        My Review for All CD200R1L Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2025 Creative BioMart. All Rights Reserved.

        Contact Us

        • /
        • Service lnquiry:

        Stay Updated on the Latest Bioscience Trends